• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Exposure of the cryptic de-adhesive site FNIII14 in fibronectin molecule and its binding to membrane-type eEF1A induce migration and invasion of cancer cells via β1-integrin inactivation.纤连蛋白分子中隐蔽的去黏附位点FNIII14的暴露及其与膜型eEF1A的结合通过β1整合素失活诱导癌细胞迁移和侵袭。
Am J Cancer Res. 2020 Nov 1;10(11):3990-4004. eCollection 2020.
2
[New Type of Antitumor Agent Targeting the Cell Adhesion Molecule, Integrin].[靶向细胞粘附分子整合素的新型抗肿瘤药物]
Yakugaku Zasshi. 2017;137(2):137-139. doi: 10.1248/yakushi.16-00229-3.
3
A new type of antimetastatic peptide derived from fibronectin.一种源自纤连蛋白的新型抗转移肽。
Clin Cancer Res. 2002 Jul;8(7):2455-62.
4
Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins.β1整合素的失活诱导Myc癌蛋白的蛋白酶体降解。
Oncotarget. 2019 Aug 13;10(48):4960-4972. doi: 10.18632/oncotarget.27131.
5
Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim.FNIII14肽的联合给药通过激活促凋亡蛋白Bim协同增强化疗药物的抗癌活性。
PLoS One. 2016 Sep 13;11(9):e0162525. doi: 10.1371/journal.pone.0162525. eCollection 2016.
6
Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.整合素激活肽源于 tenascin-C 在癌症侵袭中的作用以及使用纤连蛋白衍生的整合素失活肽的新抗癌策略。
Molecules. 2020 Jul 16;25(14):3239. doi: 10.3390/molecules25143239.
7
Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly.源自两个不同区域的纤连蛋白肽通过阻止纤连蛋白基质组装来刺激脂肪细胞分化。
Biochemistry. 2002 Mar 5;41(9):3270-7. doi: 10.1021/bi015660a.
8
Antiadhesive sites present in the fibronectin type III-like repeats of human plasma fibronectin.人血浆纤连蛋白III型样重复序列中存在的抗黏附位点。
Biol Pharm Bull. 2007 May;30(5):891-7. doi: 10.1248/bpb.30.891.
9
Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.整合素连接激酶调节骨桥蛋白依赖性基质金属蛋白酶-2和尿激酶型纤溶酶原激活剂的表达,以传递小鼠乳腺上皮癌细胞的转移功能。
Carcinogenesis. 2006 Jun;27(6):1134-45. doi: 10.1093/carcin/bgi352. Epub 2006 Feb 12.
10
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.纤连蛋白、胶原蛋白和层粘连蛋白的整合素受体在响应基质微环境调节卵巢癌功能中的作用。
Clin Exp Metastasis. 2005;22(5):391-402. doi: 10.1007/s10585-005-1262-y.

引用本文的文献

1
The In Vitro Effects of Romina Strawberry Extract on 3D Uterine Leiomyosarcoma Cells.罗米娜草莓提取物对 3D 子宫平滑肌肉瘤细胞的体外影响。
Nutrients. 2023 May 30;15(11):2557. doi: 10.3390/nu15112557.
2
Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art.针对真核延伸因子 1A 的抗癌小分子药物:现状。
Int J Mol Sci. 2023 Mar 8;24(6):5184. doi: 10.3390/ijms24065184.
3
Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis.肿瘤衍生的外泌体成分:在乳腺癌转移中的多方面作用和机制。
Cell Death Dis. 2021 May 26;12(6):547. doi: 10.1038/s41419-021-03825-2.

本文引用的文献

1
Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins.β1整合素的失活诱导Myc癌蛋白的蛋白酶体降解。
Oncotarget. 2019 Aug 13;10(48):4960-4972. doi: 10.18632/oncotarget.27131.
2
Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells.层粘连蛋白衍生肽 TNIIIA2 诱导的自分泌 PDGF 刺激诱导神经胶质瘤细胞过度增殖。
Int J Mol Sci. 2019 Jun 28;20(13):3183. doi: 10.3390/ijms20133183.
3
Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.来源于 tenascin-C 的肽 TNIIIA2 通过激活成纤维细胞中的β1 整合素促进结肠炎相关结直肠癌的恶性进展。
Int J Mol Sci. 2019 Jun 5;20(11):2752. doi: 10.3390/ijms20112752.
4
Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.层粘连蛋白衍生肽 TNIIIA2 增强整合素 α5β1 的激活导致胶质母细胞瘤细胞的侵袭性进展。
Mol Cancer Ther. 2019 Sep;18(9):1649-1658. doi: 10.1158/1535-7163.MCT-18-1251. Epub 2019 Jun 12.
5
Keratocytes Generate High Integrin Tension at the Trailing Edge to Mediate Rear De-adhesion during Rapid Cell Migration.角质形成细胞在快速细胞迁移过程中,于后缘产生高整合素张力以介导后部去黏附。
iScience. 2018 Nov 30;9:502-512. doi: 10.1016/j.isci.2018.11.016. Epub 2018 Nov 12.
6
The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration.源自腱生蛋白-C的细胞外基质肽TNIIIA2对结肠癌细胞浸润的促进作用
Int J Mol Sci. 2017 Jan 17;18(1):181. doi: 10.3390/ijms18010181.
7
Tissue invasion and metastasis: Molecular, biological and clinical perspectives.组织侵袭和转移:分子、生物和临床视角。
Semin Cancer Biol. 2015 Dec;35 Suppl:S244-S275. doi: 10.1016/j.semcancer.2015.03.008. Epub 2015 Apr 10.
8
Overexpression of eukaryotic elongation factor 1 alpha-2 is associated with poorer prognosis in patients with gastric cancer.真核生物延伸因子1α-2的过表达与胃癌患者较差的预后相关。
J Cancer Res Clin Oncol. 2015 Jul;141(7):1265-75. doi: 10.1007/s00432-014-1897-7. Epub 2015 Jan 20.
9
Is there new hope for therapeutic matrix metalloproteinase inhibition?治疗性基质金属蛋白酶抑制有新希望吗?
Nat Rev Drug Discov. 2014 Dec;13(12):904-27. doi: 10.1038/nrd4390. Epub 2014 Nov 7.
10
Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.在体外和体内生成具有侵袭性转移潜能的MCF-7细胞。
Breast Cancer Res Treat. 2014 Nov;148(2):269-77. doi: 10.1007/s10549-014-3159-4. Epub 2014 Oct 8.

纤连蛋白分子中隐蔽的去黏附位点FNIII14的暴露及其与膜型eEF1A的结合通过β1整合素失活诱导癌细胞迁移和侵袭。

Exposure of the cryptic de-adhesive site FNIII14 in fibronectin molecule and its binding to membrane-type eEF1A induce migration and invasion of cancer cells via β1-integrin inactivation.

作者信息

Itagaki Keisuke, Sasada Manabu, Miyazaki Satoru, Iyoda Takuya, Imaizumi Takahiro, Haga Makoto, Kuga Akira, Inomata Hiroki, Kondo Yosuke, Osada Satoshi, Kodama Hiroaki, Higami Yoshikazu, Fukai Fumio

机构信息

Department of Molecular Pathophysiology, Faculty of Pharmaceutical Sciences, Tokyo University of Science 2641 Yamazaki, Noda-Shi, Chiba 278-8510, Japan.

Department of Medical and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science 2641 Yamazaki, Noda-Shi, Chiba 278-8510, Japan.

出版信息

Am J Cancer Res. 2020 Nov 1;10(11):3990-4004. eCollection 2020.

PMID:33294281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7716165/
Abstract

Cell migration is a highly coordinated process that involves not only integrin-mediated adhesion but also de-adhesion. We previously found that a cryptic de-adhesive site within fibronectin molecule, termed FNIII14, weakens cell adhesion to the extracellular matrix by inactivating β1-integrins. Surprisingly, eukaryotic translation elongation factor-1A (eEF1A), an essential factor during protein biosynthesis, was identified as a membrane receptor that mediates the de-adhesive effect of FNIII14. Here, we demonstrate that FNIII14-mediated de-adhesion causes enhanced migration and invasion in two types of highly invasive/metastatic cancer cells, resulting in the initiation of metastasis. Both migration and invasion of highly invasive human melanoma cell line, Mum2B, were inhibited by a matrix metalloproteinase (MMP)-2/9 inhibitor or a function-blocking antibody against FNIII14 (anti-FNIII14 Ab), suggesting that MMP-mediated exposure of the cryptic de-adhesive site FNIII14 was responsible for Mum2B cell migration and invasion. The MMP-induced FNIII14 exposure was also shown to be functional in the migration and invasion of highly metastatic mouse breast cancer cell line 4T1. Overexpression and knockdown experiments of eEF1A in Mum2B cells revealed that the migration and invasion were dependent on the membrane levels of eEF1A. experiments using tumor xenograft mouse models derived from Mum2B and 4T1 cell lines showed that the anti-FNIII14 Ab has a significant anti-metastatic effect. Thus, these results provide novel insights into the regulation of cancer cell migration and invasion and suggest promising targets for anti-metastasis strategies.

摘要

细胞迁移是一个高度协调的过程,不仅涉及整合素介导的黏附,还涉及去黏附。我们之前发现,纤连蛋白分子内一个隐蔽的去黏附位点,称为FNIII14,通过使β1整合素失活来削弱细胞与细胞外基质的黏附。令人惊讶的是,真核生物翻译延伸因子-1A(eEF1A),一种蛋白质生物合成过程中的必需因子,被鉴定为介导FNIII14去黏附作用的膜受体。在此,我们证明FNIII14介导的去黏附在两种高侵袭性/转移性癌细胞中导致迁移和侵袭增强,从而引发转移。高侵袭性人类黑色素瘤细胞系Mum2B的迁移和侵袭均受到基质金属蛋白酶(MMP)-2/9抑制剂或针对FNIII14的功能阻断抗体(抗FNIII14抗体)的抑制,这表明MMP介导的隐蔽去黏附位点FNIII14的暴露是Mum2B细胞迁移和侵袭的原因。MMP诱导的FNIII14暴露在高转移性小鼠乳腺癌细胞系4T1的迁移和侵袭中也显示出功能。在Mum2B细胞中对eEF1A进行过表达和敲低实验表明,迁移和侵袭依赖于eEF1A的膜水平。使用源自Mum2B和4T1细胞系的肿瘤异种移植小鼠模型进行的实验表明,抗FNIII14抗体具有显著的抗转移作用。因此,这些结果为癌细胞迁移和侵袭的调控提供了新的见解,并为抗转移策略提出了有前景的靶点。